• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Cataract surgery performed in settings other than hospital operating rooms: clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal bacteriotherapy for patients with recurrent C. difficile: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques for the management of temporary epicardial pacemaker leads: clinical evidence, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Probiotics in infants: clinical effectiveness, safety and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Rasburicase for adults with acute tumor lysis syndrome: a review of clinical and cost effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Patient lifts and transfer equipment for preventing pressure ulcers: a review of clinical and cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Esophageal doppler ultrasound-based cardiac output monitoring for adults undergoing surgery: a review of clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes: clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) JC virus antibody testing for patients with MS: a review of the diagnostic accuracy and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of patients with multiple sclerosis: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Tinzaparin versus dalteparin or enoxaparin for the treatment of venous thromboembolism in adults: safety and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques to improve the use of diagnostic laboratory test ordering: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Antibiotic prophylaxis for patients with cardiac or orthopedic implants undergoing dental procedures: a review of the clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic response modifier agents as first-line treatment for patients with rheumatoid arthritis: a review of the clinical efficacy, cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Bone morphogenetic proteins for use in spinal surgery and long bone trauma surgery: a review of the clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal management systems for hospitalized adult patients: comparative clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Osteostimulative bone graft substitutes or demineralized bone matrix preparations for use in spinal Surgery and long bone trauma surgery: clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Fusidic acid for ophthalmic infections: a review of clinical and cost effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The timing of prophylactic antibiotics for surgery: a review of the clinical Evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography guided versus ultrasound guided renal biopsy: comparative evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prioritizing patients undergoing non-urgent, medically necessary cosmetic surgical procedures: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Codeine compared with other opioids for pain relief in pediatric patients: comparative clinical effectiveness, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Meperidine to relieve shivering or bladder spasm: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Inhaled tobramycin versus intravenous tobramycin for patients with cystic fibrosis: a review of the clinical effectiveness, cost effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Antibiotics for the prevention of post-cesarean section complications: clinical evidence and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal timing and frequency of follow-up care for patients receiving at-home supplemental oxygen: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Wrist sphygmomanometry versus upper arm sphygmomanometry: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of dental crowns for vital and endodontically treated teeth: a review of the clinical and cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Chlorhexidine for the prevention of surgical site infections: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Risk factors to consider for extended anticoagulant therapy: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Ondansetron for the management of chemotherapy-induced nausea and vomiting in pediatric patients: a review of the clinical effectiveness, safety and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Thrombolytic drugs for cardiac arrest: a review of the clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Discontinuation of contact precautions for antibiotic resistant organisms: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Nitrofurantoin administration in patients with renal dysfunction: clinical effectiveness, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate utilization of advanced diagnostic imaging procedures: CT, MRI, and PET/CT
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-urgent prenatal ultrasound: safety and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Standing orders for insulin administration in hospitalized patients with type I or type II diabetes: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Probiotics for antibiotic-associated diarrhea, <i>clostridium difficile</i> infection and irritable bowel syndrome: a review of clinical evidence and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of medical marijuana: guidelines and recommendations
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Repetitive transcranial magnetic stimulation for specific patient populations: clinical and cost-effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Metal-ceramic versus all-ceramic dental crowns: a review of the clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Suboxone for the treatment of chronic non-cancer pain: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Metronidazole powder and cream for odour control in acute, chronic, and palliative wounds: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Neuromuscular occlusion concept-based diagnosis and treatment of tempromandibular joint disorders: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac troponin for the diagnosis of acute coronary syndrome in the emergency department: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal method for driving assessment in older adults and in patients who have had a cerebrovascular accident: clinical evidence, cost-effectiveness, and guidelines
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantation genetic screening (PGS) in patients undergoing high-complexity reproduction technologies]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Detection of sperm DNA fragmentation (TUNEL, SCSA, SCD, COMET) and use of annexin columns (MACS) in assisted reproduction treatments]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Whole exome sequencing for patients with intellectual disability/mental retardation or ASD]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Laparoscopic vertical sleeve gastrectomy vs. laparoscopic Roux-en Y gastric bypass for the treatment of obesity]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Tocilizumab for the treatment of rheumatoid arthritis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Temozolomide for anaplastic oligodendroglioma]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Thiopurine-methyltransferase genotyping prior to thiopurine therapy]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Chromosomal microarrays for the etiologic diagnosis in patients with intellectual disability, developmental delay or autism spectrum]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Risk-reducing surgery in BRCA1 or 2 mutation carriers]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Use of antibiotic-loaded bone cement in primary hip and knee arthroplasty]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Brentuximab vedotin for Hodgkin´s lymphoma]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Miglustat for patients with niemann-pick disease type C]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Drug-eluting stents in coronary heart disease]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Ultrasensitive C-reactive protein as a prognostic biomarker for cardiovascular disease]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for the diagnosis of breast cancer]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [MRI enterography for the assessment of inflammatory bowel disease]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Denosumab versus bisphosphonates for the treatment of osteoporosis in post-menopausal women]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Actualization: radiofrequency sympathetic denervation of the renal arteries for refractory arterial hypertension]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Music therapy - update on the evidence about its indications]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Biofeedback for women with urinary, fecal or combined incontinence]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Fulvestrant for the treatment of locally advanced ormetastatic breast cancer]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Etanercept, adalimumab, infliximab and golimumab for the treatment of juvenile idiopathic arthritis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Laparoscopic (non robotic) radical prostatectomy versus open radical prostatectomy in localized prostate cancer]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Cidofovir for the treatment of recurrent respiratory papillomatosis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Inhalation tobramycin for the management of cystic fibrosis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Bravo pH monitoring in gastroesophageal reflux]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking for keratoconus patients]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Aflibercept for age-related macular degeneration and central retinal vein occlusion]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Three-dimensional stereoscopic vision system laparoscopy using monitors in gastroenterological, thoracic, urologic and gynecological conditions]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Adalimumab, etanercept, infliximab and golimumab for the treatment of ankylosing spondylitis and reactive arthritis]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Implantable and programmable sacral neuromodulator (Interstim®) treatment of urinary, fecal and combined incontinence]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Lapatinib or trastuzumab in combination with aromatase Inhibitors for hormone receptor positive/ErbB2-positive breast cancer]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Steady-state auditory evoked potentials (SSAEPs) in patients with hypoacusia who can not collaborate]
2013 HAYES, Inc. SensiGene fetal RHD genotyping
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intraoperative radiation therapy in the treatment of breast cancer]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficacy and safety of percutaneous and transapical aortic valve implantation in the treatment of severe aortic stenosis. Systematic review]
2013 HAYES, Inc. Autologous Stem Cell Transplantation (ASCT) for Metastatic Primitive Neuroectodermal Tumor (PNET)
2013 HAYES, Inc. Automated percutaneous lumbar discectomy
2013 HAYES, Inc. Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults
2013 HAYES, Inc. Biological mesh for abdominal hernia repair
2013 HAYES, Inc. Dry needling for myofascial pain in adults
2013 HAYES, Inc. Endovascular repair of isolated iliac artery aneurysms
2013 HAYES, Inc. Extracorporeal shock wave therapy for chronic plantar fasciitis
2013 HAYES, Inc. Fecal calprotectin assay for management of crohn's disease
2013 HAYES, Inc. Gastric electrical stimulation for gastroparesis